Tine Norman Alver

Abstract Targeted therapies have become mainstream anticancer treatments, although their efficacy is limited by low response rates, drug resistance, and therapy-related toxicities. Drug combinations have the potential to overcome these challenges. However, identifying effective drug combinations is a major challenge. Focusing on melanoma, we systematically interrogated drug-drug interactions to identify synergistic and antagonistic drug combinations.